IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$1.45
+9.85%Oct 2, 2026, 11:30 UTC
InflaRx N.V. announced it was selected for a late-breaking poster session presenting pre-clinical data on izicopan at the American Society of Nephrology's Kidney Week 2026 in Denver, Colorado, October 21-25.
Source: